skip to Main Content

Supreme Court stayed the Delhi High Court order of injunction against Glenmark over the Generic drug “Sitagliptin”

Reportedly, Hon’ble Supreme Court of India on Special Leave Petition filed by Glenmark stayed the Delhi High Court order which passed an injunction against Glenmark for the generic drug Sitagliptin till 28th April 2015. The Delhi high court dated 20th…

Amendment in Design Rules and Fee

Controller General of Patents, Design and Trade Marks, Mr. Chaitanya Prasad, has issued a Public Notice on 1 January 2015, wherein it has been put forth that, from December 31, 2014, Official Fees for filing a new Design application as…

Cipla’s plea for revocation of Novartis Patents for Onbrez may face major set back by the Government

As reported in TOI, the Indian Government has found very little merit in Cipla’s plea for waiver and cancellation of Patent rights for chronic obstructive pulmonary disease (COPD) drug over which Novartis has exclusive rights. We have reported on Cipla’s…

Omnibus Claims

Omnibus is a Latin word meaning ‘For all, for everyone’. The dictionary defines omnibus as ‘A printed anthology of the works of one author or of writings on related subjects’. The key discussion in this article will be pertaining to…

Business Method Patents

During the recent visit of the Indian Prime Minister to the USA, one of the issues that figured prominently in the talk agenda was IP-related issues. American business community especially those from the pharmaceutical industry had been lobbying with their…

Back To Top